Viewing nowBC Atorvastatin Tablets (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
BC World Pharma Co., Ltd.

MFDS item code 200705819 · Notified 2007.05.21 · Insurance code 653100600
Reduces the risk of myocardial infarction and stroke and improves hyperlipidemia
This medication decreases the risk of myocardial infarction and stroke in adults with various risk factors for coronary artery heart disease and patients with type 2 diabetes, and reduces the risk related to vascular interventions and angina. Moreover, it significantly reduces the risk of fatal and non-fatal myocardial infarction, stroke, and hospitalization due to congestive heart failure in patients with clinically evident coronary artery heart disease, thereby improving overall cardiovascular health. This drug helps lower total cholesterol, LDL cholesterol, Apo-B protein, and triglycerides while increasing HDL cholesterol in patients with primary hypercholesterolemia and various dyslipidemias. It can be used in combination with or as an alternative to other treatments in patients with hyperlipidemia that are not controlled by diet alone, or in patients with homozygous familial hypercholesterolemia. In pediatric patients with heterozygous familial hypercholesterolemia, this medication may be used as an adjunct to reduce the risk of cardiovascular disease. Overall, this medication is used to reduce the risks associated with cardiovascular disease and hyperlipidemia and to improve cardiovascular health by managing blood lipid levels.
In the case of hyperlipidemia, the recommended starting dose is 10 mg atorvastatin once daily, and for patients requiring more LDL cholesterol reduction, it can be started at 20 mg or 40 mg once daily. This medication is administered in a dosage range of 10-80 mg once daily. The initial and maintenance doses should be individualized based on treatment goals and patient characteristics, and lipid levels should be analyzed within 2-4 weeks after initiation of therapy.
The recommended starting dose for pediatric patients (10-17 years) with heterozygous familial hypercholesterolemia is 10 mg once daily, with a maximum recommended dose of 20 mg once daily. The dose should be adjusted every 4 weeks or more as needed based on individual response.
This medication may cause muscle problems; if symptoms of muscle pain or weakness occur, discontinue use immediately and consult a physician. Do not take this medication if you have certain liver diseases or extremely high liver function test results. It is not to be administered to patients with muscle disorders, women who are pregnant, children under the age of 10, or patients taking certain medications. Patients with a history of alcohol abuse or liver disease should use this medication with caution, and if there is a risk of muscle-related disorders, muscle enzyme levels should be checked before treatment. While this medication is generally well tolerated, rare side effects such as liver function abnormalities, muscle pain, indigestion, headache, allergic reactions can occur. Regular liver function and muscle enzyme tests should be performed while taking this medication, and any unusual symptoms should be reported to a physician immediately. This medication can interact with other drugs, so inform your physician or pharmacist of any other medications being taken. Particular care should be taken when used in conjunction with specific antibiotics, antifungals, antivirals, immunosuppressants, grapefruit juice, etc. Women who are pregnant or breastfeeding should not take this medication, and fertile women should use appropriate contraceptive methods during treatment. The elderly or patients with impaired kidney function are at a greater risk for muscle damage and should exercise additional caution. In case of overdose, there is no specific antidote, and treatment should be symptomatic. Keep out of reach of children.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, desquamation, oral/ocular mucous membrane pain, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headaches, lightning-like headaches, seizures, confusion, visual disturbances, paralysis, urination problems
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to maintain a temperature between 1 to 30 degrees Celsius at room temperature.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
BC World Pharma Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.